Polymatech Electronics has taken a huge step in India’s medical technology landscape by launching a near-infrared (NIR) vein detection light. It is one of the first companies to register and manufacture vein finder devices under CDSCO norms. The combination of a regulated medical-device launch and growing semiconductor production shows how the company is moving beyond components to build a more diversified technology business.
India’s First CDSCO-Cleared Vein Finder
This new vein finder by Polymatech is India’s first such device to get a clearance certificate from the Central Drugs Standard Control Organisation (CDSCO). Such regulatory approval confirms its classification as a proper, compliant medical device, which differentiates it from the usually available imported alternatives. India’s push for localisation in both electronics and healthcare equipment closely aligns with this product, as it is built using indigenous compound semiconductor technology.
The device uses near-infrared light at approximately 850 nm to visualise subdermal veins. At this wavelength, haemoglobin absorbs light differently from surrounding tissue, causing veins to appear darker when illuminated. The system converts this contrast into real-time, full-HD images at 1920x1080 resolution, allowing clinicians to see vein patterns clearly beneath the skin.
Clinical Uses
Vein location in critically ill patients is a bit challenging and can cause discomfort in the long run. Polymatech’s vein finder can ease these difficulties by helping clinicians identify veins more quickly and with greater accuracy. This device can be used in hospitals, emergency rooms, neonatal & nephrology units, ambulances, home care settings, along with IV hydration centres. This device not only assists in needle placements but also in spotting infiltration and extravasation where the IV fluids or medications can leak into the surrounding tissu,e which helps the healthcare staff to react earlier and reduce potential harm.
Indigenous Tech Focus
At the heart of the vein finder is Polymatech’s in-house near-infrared LED platform, which is built on the company’s work with NIR chips since 2021. By keeping LED production and key electronic subsystems within the group, Polymatech has reduced its dependence on external suppliers, strengthening supply-chain reliability.
At present, printed circuit boards are manufactured at the company’s subsidiary in Estonia. Polymatech plans to gradually shift and expand this capability to its Raipur facility in Chhattisgarh as part of its localisation roadmap.
Financial growth and analysis for FY25
The launch of the medical device comes at a time of strong financial growth year for Polymatech. In FY25, the company posted strong gains in revenue, profits, and cash flows, supported by the expansion of its semiconductor operations and its move into higher-value segments such as medical technology.
Profit and loss metrics
Metric | FY23 | FY24 | FY25 |
Revenue (Rs. crore) | 649.7 | 1,237.6 | 1,912.1 |
EBITDA (Rs. crore) | 186.1 | 320.3 | 496.3 |
EBITDA Margin | 28.6% | 25.9% | 26.0% |
PAT (Rs. crore) | 166.8 | 240.1 | 375.6 |
PAT Margin | 25.7% | 19.5% | 19.9% |
Revenue rose 54.5% year-on-year in FY25, while net profit increased to Rs 375.6 crore. Operating margins remained stable at around 26%, indicating that growth was achieved without significant margin erosion.
Cash Flow Trends
Asset expansion accompanied revenue growth. Total assets increased to Rs 3,081.5 crore in FY25, up 91% from the previous year, reflecting investments in manufacturing capacity and higher working capital. Equity strengthened to Rs 1,172.1 crore, supported by growing reserves, although the debt-to-equity ratio rose to 1.60 due to expansion-related borrowing.
Also Read: Polymatech Latest Financial Performance And Growth Analysis.
Cash Flow Summary
Activity (Rs. crore) | FY23 | FY24 | FY25 |
Operating Cash Flow | 44.3 | 253.8 | 439.2 |
Investing Cash Flow | -80.4 | -477.2 | -102.2 |
Financing Cash Flow | 77.3 | 204.1 | 33.1 |
Net Cash Flow | 41.3 | -19.3 | 370.2 |
Operating cash flow nearly tripled in FY25, signalling improved earnings quality and working-capital management. With capital expenditure moderating after heavy FY24 investments, net cash flow turned strongly positive, lifting cash and equivalents to Rs 392.3 crore.
Global Expansion Plans
Eswara Rao Nandam, Managing Director and Chief Executive Officer of Polymatech Electronics Ltd, said the milestone reflects the company’s focus on building regulated, technology-driven medical devices in India. He noted that the combination of indigenous NIR LED technology, clinician-led design inputs, and full CDSCO compliance is intended to strengthen the domestic medical-device ecosystem.
Looking ahead, Polymatech is working toward global certifications, including approvals from the US Food and Drug Administration, CE marking for Europe, and registrations across GCC and ASEAN markets. In parallel, the company is preparing for wider distribution across India through authorised sales and service channels. Thus, proving to be an attractive investment opportunity,
